FEG is starting to look highly undervalued on the returns from Woyla alone.
An MC of $40 million is equivalent to a cheap option for a company that could easily support a $500 mio+ valuation once the resource is formally delineated.
I think the company needs to explain the possible paths to commercialisation, as a high degree of investor scepticism is contributing to the massive valuation gap.
Ann: Aloe Rek dleivers High Grade Assays, page-2
Add FEG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $30.91M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $1.32K | 11.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9613 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 59999 | 2 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
12.5¢ |
Change
0.010 ( 13.6 %) |
||||
| Open | High | Low | Volume | ||
| 12.5¢ | 12.5¢ | 12.5¢ | 18100 | ||
| Last updated 11.32am 03/06/2024 ? | |||||
| FEG (ASX) Chart |